(NASDAQ: OPK) Opko Health's forecast annual revenue growth rate of -1.89% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.39%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.87%.
Opko Health's revenue in 2025 is $664,029,000.On average, 4 Wall Street analysts forecast OPK's revenue for 2025 to be $493,701,137,849, with the lowest OPK revenue forecast at $463,807,278,354, and the highest OPK revenue forecast at $509,529,166,482. On average, 4 Wall Street analysts forecast OPK's revenue for 2026 to be $479,482,106,911, with the lowest OPK revenue forecast at $467,696,813,976, and the highest OPK revenue forecast at $498,090,756,622.
In 2027, OPK is forecast to generate $510,854,783,725 in revenue, with the lowest revenue forecast at $505,242,739,470 and the highest revenue forecast at $516,466,827,979.